Vifor Pharma, a Swiss global specialty pharmaceutical company, has named Stefan Schulze as its new CEO effective 14 May 2020, it was reported on Thursday.
Presently, Schulze has been the president of the Executive Committee and chief operating officer since 2017.
Schulze, an engineer by education, spent his professional career in the healthcare industry in the United States and Europe. He was working for the Fresenius Group in various positions from 1992 to 2014. In 2014 he became CEO of Vifor Fresenius Medical Care Renal Pharma.
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
WuXi Biologics honoured for water security by CDP
Clario acquires imaging provider NeuroRx
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services